Farzaneh-Far Ramin

CIK 00016881951 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001688195

Recent Transactions

50 trades

Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−62,500→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−11,110→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−133,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−90,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−73,654→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2020-04-02−10,416→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Common Stock
2020-04-02$48.00/sh−14,492→ 0 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-03-16−1,389→ 11,110 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-03-16$45.16/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-03-16−9,206→ 73,654 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-03-16$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-03-16$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-02-18$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-02-18$5.60/sh+9,206→ 17,727 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-02-18$46.61/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-02-18−1,389→ 12,499 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-02-18−9,206→ 82,860 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-01-15$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-01-15$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-01-15−9,206→ 92,066 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2020-01-15−1,389→ 13,888 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2020-01-15$46.95/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-12-16−1,389→ 15,277 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-12-16$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-12-16−9,206→ 101,272 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-12-16$47.23/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-12-16$5.60/sh+1,389→ 8,521 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-11-15$46.66/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-11-15$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-11-15−9,206→ 110,478 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-11-15$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-11-15−1,389→ 16,666 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-10-15$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-10-15−9,206→ 119,684 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-10-15$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-10-15−1,389→ 18,055 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-10-15$46.89/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-09-16$5.60/sh+1,389→ 8,521 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-09-16−1,389→ 19,444 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-09-16$5.60/sh+9,206→ 17,727 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-09-16$25.26/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-09-16−9,206→ 128,890 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-08-23−9,206→ 138,096 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-08-23−1,389→ 20,833 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-08-23$5.60/sh+9,206→ 17,727 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-08-23$5.60/sh+1,389→ 8,521 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-08-23$27.77/sh−10,595→ 7,132 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-07-15−1,389→ 22,222 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-07-15$32.97/sh−6,379→ 11,348 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-07-15$5.60/sh+1,389→ 8,521 total

Companies

Ra Pharmaceuticals, Inc.
Chief Medical Officer

Recent Filings

Address

C/O RA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140

View on SEC.gov